Zim Laboratories Share Price

NSE
ZIMLAB •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or Open Demat Account for live prices.
Start SIP in Zim Laboratories
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
Near 52W Low of ₹89.90
-10.2
TTM PE Ratio
Below industry Median
29.7
Price to Book Ratio
Below industry Median
1.9
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is negative
-4.7

Zim Laboratories Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Zim Laboratories Quarterly Revenue

Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
96.33 Cr
92.14 Cr
81.82 Cr
117.86 Cr
96.29 Cr

Zim Laboratories Yearly Revenue

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
372.61 Cr
404.94 Cr
337.83 Cr
309.6 Cr
282.26 Cr

Zim Laboratories Quarterly Net Profit/Loss

Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
4 Cr
2.38 Cr
0.9 Cr
8.09 Cr
4.78 Cr

Zim Laboratories Yearly Net Profit/Loss

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
17.25 Cr
24.43 Cr
14.55 Cr
7.32 Cr
3.3 Cr
Zim Laboratories Result Highlights
  • Zim Laboratories Ltd reported a 4.9% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a growth of 0.7%.

  • Its expenses for the quarter were up by 2.1% QoQ and 2.2% YoY.

  • The net profit increased 68.1% QoQ and decreased 16.3% YoY.

  • The earnings per share (EPS) of Zim Laboratories Ltd stood at 0.8 during Q3FY25.

    Read more

Data Source: BSE, Company announcements

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

Zim Laboratories shareholding Pattern

Promoter
33.3%
Foreign Institutions
0.2%
Domestic Institutions
0.2%
Public
66.3%
Promoter
33.3%
Domestic Institutions
0.1%
Public
66.6%
Promoter
33.3%
Domestic Institutions
0.1%
Public
66.6%
Promoter
33.3%
Public
66.7%
Promoter
33.3%
Public
66.7%
Promoter
33.3%
Public
66.8%

Zim Laboratories Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
16
5Day EMA
95.20
10Day EMA
96.70
12Day EMA
97.20
20Day EMA
98.80
26Day EMA
99.70
50Day EMA
102.50
100Day EMA
105.30
200Day EMA
107.20
5Day SMA
95.20
10Day SMA
96.80
20Day SMA
99.60
30Day SMA
100.50
50Day SMA
103.50
100Day SMA
106.40
150Day SMA
108.60
200Day SMA
108.40
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
518041 Rs
568080 Rs
Week Rs
142181 Rs
170346 Rs
Month Rs
98461 Rs
120810 Rs
Resistance & Support
95.23
Pivot
Resistance
First Resistance
96.97
Second Resistance
100.38
Third Resistance
102.12
Support
First Support
91.82
Second support
90.08
Third Support
86.67
Relative Strength Index
37.08
Money Flow Index
13.64
MACD
-2.51
MACD Signal
-2.01
Average True Range
4.54
Average Directional Index
20.23
Rate of Change (21)
-7.60
Rate of Change (125)
-18.19

Zim Laboratories Company background

Founded in: 1984
Managing director: Anwar S Daud
Zim Laboratories Ltd was incorporated in February, 1984 under the name and style of Zim Laboratories Private Limited in the State of Maharashtra. The Company became a Public Limited Company through fresh Certificate of Incorporation issued by the Registrar of Companies, Maharashtra, Mumbai. The Company is engaged in the manufacturing of formulation on drugs and pre formulation ingredients in India and marketing and selling these within and outside India. The Pharma Industry is dominated by Multinationals, Large Indian companies and in the lower end of the market large number of units mainly in the SSI sector.During the year 201920, ZIM Health Technologies Limited was acquired thereby resulting as a wholly owned subsidiary of the company . SIA ZIM Laboratories Limited got incorporated as a wholly owned subsidiary in Latvia.In 2023, the Company launched Thinoral (Patented Oral Thin Film technology) as an alternate drug delivery platform across RoW/Pharmerging Markets and EU.
Read More

Zim Laboratories FAQs

Zim Laboratories share price is ₹95.05 in NSE and ₹93.55 in BSE as on 20/2/2025 12:00:00 AM. Please be aware that stock prices are subject to continuous fluctuations due to various factors.

Zim Laboratories share price in the past 1-year return was -15.95. The Zim Laboratories share hit a 1-year low of Rs. 89.5 and a 1-year high of Rs. 131.4.

The market cap of Zim Laboratories is Rs. 463.14 Cr. as of 20/2/2025 12:00:00 AM.

The PE ratios of Zim Laboratories is 32.04 as of 20/2/2025 12:00:00 AM.

The PB ratios of Zim Laboratories is 1.94 as of 20/2/2025 12:00:00 AM

You can easily buy Zim Laboratories shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -